Diagnosis and Metaphylaxis of Stone Disease. Consensus Concept of the National Working Committee on Stone Disease for the Upcoming German Urolithiasis Guideline

Overview

Journal World J Urol

Specialty Urology

Date 2005 Nov 30

PMID 16315051

Citations 35

Authors

M Straub

W L Strohmaier

W Berg

B Beck

B Hoppe

N Laube

S Lahme

M Schmidt

A Hesse

K U Koehrmann

Affiliations

Soon will be listed here.

Abstract

This review draws the recent state of the art in metabolic diagnosis and metaphylaxis of stone disease. It is the basis for the consensus approval with the other medical societies and institutions in Germany involved in the guideline process of the new "Urolithiasis Guideline". The German Working Committee on Stone Disease reviewed critically the current literature in the field of urolithiasis-including the existing German and EAU-Guidelines as well as the Conference Book of the First International Consultation on Stone Disease. As far as possible the references were rated according to the EBM criteria. On this basis the expert group discussed all pathways and statements regarding the management of stone disease. The present review coincides with the consented guideline draft of the German Working Committee on Stone Disease. Occurrence of stone disease in the western world increases seriously. Modern lifestyle, dietary habits and overweight-problems of the affluent societies-emerge to be the important promoters of the "stone-boom" in the new millennium. This even affects children, whose stone prevalence is otherwise significantly less than that of adults. Criteria for the high risk group of stone formers were clearly defined. A diagnostic standard is formulated for the basic and the elaborate metabolic evaluation of a stone patient. Approximately 75% of all stone patients could anticipate stone recurrence with elementary reorientation of their lifestyle and dietary habits, summarized as general metaphylaxis. About 25% of the stone formers require additional pharmacological intervention to normalize their individual biochemical risk, precisely compiled for each stone type as specific metaphylaxis.

Citing Articles

Analysis of components and related risk factors of urinary stones: a retrospective study of 1055 patients in southern China.

Wang Y, Zhu Y, Luo W, Long Q, Fu Y, Chen X Sci Rep. 2024; 14(1):28357.

PMID: 39550454 PMC: 11569250. DOI: 10.1038/s41598-024-80147-1.

Predictive role of ureteral wall thickness and patient characteristics in endoscopic treatment outcomes for ureteral stricture disease following stone surgery.

Sahin C, Sinanoglu O, Sobay R, Arikan O, Uslu M, Bicaklioglu F World J Urol. 2024; 42(1):258.

PMID: 38662213 PMC: 11045613. DOI: 10.1007/s00345-024-04978-3.

The Saudi urological association guidelines on urolithiasis.

Kamal W, Azhar R, Hamri S, Alathal A, Alamri A, Alzahrani T Urol Ann. 2024; 16(1):1-27.

PMID: 38415236 PMC: 10896325. DOI: 10.4103/ua.ua_120_23.

Neural Network Analysis of Crystalluria Content to Predict Urinary Stone Type.

Almannie R, Alsufyani A, Alturki A, Almuhaideb M, Binsaleh S, Althunayan A Res Rep Urol. 2022; 13:867-876.

PMID: 35004390 PMC: 8721952. DOI: 10.2147/RRU.S322580.

Clinical and Radiological Predictors of Early Intervention in Acute Ureteral Colic.

Abushamma F, Ktaifan M, Abdallah A, Alkarajeh M, Maree M, AwadGhanem A Int J Gen Med. 2021; 14:4051-4059.

PMID: 34354367 PMC: 8331218. DOI: 10.2147/IJGM.S322170.

References

Pearle M, Roehrborn C, Pak C . Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999; 13(9):679-85. DOI: 10.1089/end.1999.13.679. View

Burgos F, Sanchez J, Avila S, Saez J, Escudero Barrilero A . [The usefulness of computerized axial tomography (CT) in establishing the composition of calculi]. Arch Esp Urol. 1993; 46(5):383-91. View

Curhan G, Curhan S . Dietary factors and kidney stone formation. Compr Ther. 1994; 20(9):485-9. View

Tiselius H, Ackermann D, Alken P, Buck C, Conort P, Gallucci M . Guidelines on urolithiasis. Eur Urol. 2001; 40(4):362-71. DOI: 10.1159/000049803. View

Hoppe B, Latta K, von Schnakenburg C, Kemper M . Primary hyperoxaluria--the German experience. Am J Nephrol. 2005; 25(3):276-81. DOI: 10.1159/000086358. View

Vant Hoff W . Aetiological factors in paediatric urolithiasis. Nephron Clin Pract. 2004; 98(2):c45-8. DOI: 10.1159/000080251. View

Goldfarb D, Coe F . Beverages, diet, and prevention of kidney stones. Am J Kidney Dis. 1999; 33(2):398-400; discussion 401-3. DOI: 10.1016/s0272-6386(99)70319-7. View

Curhan G, Willett W, Speizer F, Stampfer M . Beverage use and risk for kidney stones in women. Ann Intern Med. 1998; 128(7):534-40. DOI: 10.7326/0003-4819-128-7-199804010-00003. View

Cochat P, Gaulier J, Koch Nogueira P, Feber J, Jamieson N, Rolland M . Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr. 1999; 158 Suppl 2:S75-80. DOI: 10.1007/pl00014327. View

10.

Hesse A, Kruse R, Geilenkeuser W, Schmidt M . Quality control in urinary stone analysis: results of 44 ring trials (1980-2001). Clin Chem Lab Med. 2005; 43(3):298-303. DOI: 10.1515/CCLM.2005.051. View

11.

Osborne C, Lulich J, Bartges J, Ulrich L, Koehler L, Bird K . Drug-induced urolithiasis. Vet Clin North Am Small Anim Pract. 1999; 29(1):251-66, xiv. DOI: 10.1016/s0195-5616(99)50014-4. View

12.

Schneider H, Hesse A, HIENZSCH E, Tscharnke J, Schweder P . [Roentgen examinations as standardized urinary calculi structure analysis in the German Democratic Republic (experience from 3500 urinary calculi analyses)]. Z Urol Nephrol. 1974; 67(2):111-9. View

13.

Borghi L, Meschi T, Amato F, NOVARINI A, Romanelli A, Cigala F . Hot occupation and nephrolithiasis. J Urol. 1993; 150(6):1757-60. DOI: 10.1016/s0022-5347(17)35887-1. View

14.

Hesse A, Siener R, Heynck H, Jahnen A . The influence of dietary factors on the risk of urinary stone formation. Scanning Microsc. 1993; 7(3):1119-27; discussion 1127-8. View

15.

von Unruh G, Voss S, Sauerbruch T, Hesse A . Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test. J Urol. 2003; 169(2):687-90. DOI: 10.1097/01.ju.0000051637.63068.92. View

16.

Sheir K, Mansour O, Madbouly K, Elsobky E, Abdel-Khalek M . Determination of the chemical composition of urinary calculi by noncontrast spiral computerized tomography. Urol Res. 2005; 33(2):99-104. DOI: 10.1007/s00240-004-0454-2. View

17.

Ettinger B, Citron J, Livermore B, Dolman L . Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol. 1988; 139(4):679-84. DOI: 10.1016/s0022-5347(17)42599-7. View

18.

Barbey F, Joly D, Rieu P, Mejean A, Daudon M, Jungers P . Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol. 2001; 163(5):1419-23. DOI: 10.1016/s0022-5347(05)67633-1. View

19.

Leyva M . The role of dietary calcium in disease prevention. J Okla State Med Assoc. 2003; 96(6):272-5. View

20.

Birwe H, SCHNEEBERGER W, Hesse A . Investigations of the efficacy of ascorbic acid therapy in cystinuria. Urol Res. 1991; 19(3):199-201. DOI: 10.1007/BF00303750. View